Drug Shortage Report for RIXUBIS
Report ID | 198627 |
Drug Identification Number | 02431955 |
Brand name | RIXUBIS |
Common or Proper name | Recombinant Coagulation Factor IX (rFIX) |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | NONACOG GAMMA |
Strength(s) | 2000UNIT |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 mL Vial |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-07-13 |
Actual start date | 2023-07-13 |
Estimated end date | 2023-08-31 |
Actual end date | 2023-08-28 |
Shortage status | Resolved |
Updated date | 2023-08-28 |
Company comments | Possible complaints on BAXJECT II Transfer Device co-packaged with RIXUBIS drug product |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-08-28 | French | Compare |
v5 | 2023-08-28 | English | Compare |
v4 | 2023-07-14 | English | Compare |
v3 | 2023-07-13 | French | Compare |
v2 | 2023-07-13 | English | Compare |
v1 | 2023-07-13 | English | Compare |
Showing 1 to 6 of 6